United States

People: ImmunoGen Inc (IMGN.OQ)

IMGN.OQ on NASDAQ Stock Exchange Global Select Market

20 Jan 2017
Change (% chg)

$-0.05 (-2.02%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Johnston, David 

Mr. David B. Johnston is Executive Vice President and Chief Financial Officer of the Company. Mr. Johnston joined ImmunoGen in 2013, and has served as our Executive Vice President and Chief Financial Officer since that date. Prior to joining ImmunoGen, Mr. Johnston served as Chief Financial Officer of AVEO Pharmaceuticals, Inc., a biotechnology company, from 2007 to 2013. Mr. Johnston holds a Master of Business Administration from the University of Michigan.

Basic Compensation

Total Annual Compensation, USD 506,444
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 634,402
Fiscal Year Total, USD 1,140,850

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --